PQE Group

Latest Insights

Next Generation Products

New Challenges for Governments: Reduced Risk Tobacco Products alternatives and Tobacco Control Policies

Many countries are working to implement or improve their Tobacco risk reduction policy, to ensure a lower rate of diseases and deaths connected to.

Medical Cannabis

Cannabis Products: Last Decades Progresses

Last decade has witnessed an increasing interest in the Cannabis field considering every aspect, from business applications to more scientific and.

GxP Compliance

How to perform a robust Vaccine Technology Transfer in a challenging era

Vaccine Technology Transfer is a core challenge for pharmaceutical companies that are involved in the fight to Covid-19.

Cybersecurity

5 questions (plus, a bonus one) you should be able to answer to ensure the security of your systems

Find out from PQE experts cyberthreats may affect your Operation Technology and what Practices to perform to put OT at safe.

CSV & Data Integrity

A comparison between CSV Guideline / regulations in Japan, India and China

Find out the differences between CSV guidelines and regulations in Japan, India and China.

Annex 1

2020 Annex 1 draft: new challenges for sterile manufacturers

The new Annex 1 is a milestone standard for all sterile manufacturers, with important insights and implementations for the sterility assurance of the.

IT Operations

The future of blockchain in healthcare

Blockchain is an increasingly widespread technology that is approaching a stage of maturity that could see an explosion of use also in the health.

GxP Compliance

CMDh raising risk awareness on Nitrosamines Impurities

Manufacturers of API and finished products should cooperate with MAHs to prevent nitrosamine formation and contamination of human medicinal products.

Next Generation Products

Vaping suspected for health consequences, needs regulation

E-cigarette and vaping is on the rise, but what are the possible health consequences? Learn more in this PQE Group's article.